KrazyAnneBanks
Well-Known Member
kill the rat
DEA set to reschedule to schedule II this summer?
- Thread starter BOBBY_G
- Start date
kill the rat
Olive Drab Green
Well-Known Member
ttystikk
Well-Known Member
Olive Drab Green
Well-Known Member
Impalement would probably make 'em suffer. Might send a message, too.
ttystikk
Well-Known Member
But you can't put Glaxo SmithKline Welcome on a stick. Fuck, even the damned name is too thick!
Olive Drab Green
Well-Known Member
Strychnine, then. They'll suffer and convulse for three days, incurably, and die.
ttystikk
Well-Known Member
Poisoned by their own drugs. Fitting.
BarnBuster
Virtually Unknown Member
Update: It's unofficially official. A senior executive at the Drug Enforcement Administration has confirmed that the DEA will not be rescheduling marijuana in 2016, says a local attorney who spoke with him late last week. "The DEA is not going to reschedule marijuana this year.... They aren't issuing a public announcement about the change," the attorney adds.
Many marijuana advocates — and the legislators who support them — have been hoping that the DEA would reschedule marijuana from a Schedule I to a Schedule II substance. The reclassification would acknowledge that the drug holds medical value and allow for more research.
As we reported last month (see original story below), the DEA had sent a letter to lawmakers in April, saying that the agency would release an announcement on rescheduling in the first half of this year. But July 1 came and went with no announcement, and the DEA has refused to set a new timeline.
"We do not have a date set to make an announcement about that one way or another," a representative in the DEA's public-affairs office said today
http://www.westword.com/news/deas-marijuana-rescheduling-announcement-may-not-come-in-2016-8090675
Many marijuana advocates — and the legislators who support them — have been hoping that the DEA would reschedule marijuana from a Schedule I to a Schedule II substance. The reclassification would acknowledge that the drug holds medical value and allow for more research.
As we reported last month (see original story below), the DEA had sent a letter to lawmakers in April, saying that the agency would release an announcement on rescheduling in the first half of this year. But July 1 came and went with no announcement, and the DEA has refused to set a new timeline.
"We do not have a date set to make an announcement about that one way or another," a representative in the DEA's public-affairs office said today
http://www.westword.com/news/deas-marijuana-rescheduling-announcement-may-not-come-in-2016-8090675
Olive Drab Green
Well-Known Member
Doesn't matter. Shit's about to get real federally, anyway.
Rob Roy
Well-Known Member
All regulatory agencies exist to transfer wealth by ensuring that connected people benefit and to punish disobedient serfs, while convincing obedient serfs that without them, things would be scary and chaotic. It's a scam, which features fear mongering.
I have a schedule that suits me, because I own myself, "they" don't own me.
The DEA is just one of the many alphabet soup violent government gangs masquerading as "public servants" or " government departments" which use violence as their principle tool and primary means. Fuck them all. They are thugs.
It's worth saying again, fuck them all.
I have a schedule that suits me, because I own myself, "they" don't own me.
The DEA is just one of the many alphabet soup violent government gangs masquerading as "public servants" or " government departments" which use violence as their principle tool and primary means. Fuck them all. They are thugs.
It's worth saying again, fuck them all.
Dr. Who
Well-Known Member
Ok kiddies.
Their waiting for the TRUMP card to hit office (THEY hope), and still with Hillery things won't change (How would you take away the DEA's bread and butter? Everything they do and the biggest portion of the busts they make, are marijuana! The BULK of any cash and drugs reported as "confiscated" are from marijuana, is marijuna! You DON"T take cash from the FEDS and you don't shut down their biggest subdivision.)
BUT, it's the Trump card they want! Trump is anti drugs and very anti MM! If elected, what do you think he will do? I'll bet he would let loose the dogs of war and the DEA along with the anyone attached to them (AG's office) would throw down on MM and lets not even mention the "legal" states! Think it couldn't happen? All the Feds have to do is start denying federal funds for schools, roads, municipalities, etc, etc. To simply pressure the state into "compliance" with Federal law! This is the "trump" card in their back pocket! They will send the IRS down on business's related to MM and legal marijuana like sharks to a dead bleeding whale! All the real anti's in government have been doing is waiting for a dip shit like Trump to give a green light. Any thing fails and they point their finger at him and say "He said too"!
VOTE CAREFULLY and keep your head down.
Marijuana is not leaving schedule 1 anytime soon! While the drug companies would loose too much cash - so would the parts of government made to fight the "war" on drugs! Can't kill your cash cow and graven image!
THIS GUY knows his shit!
WELL SAID!
BM9AGS
Well-Known Member
He's for sure the lesser of evils. Hillery will make our military and Defence so week we will no longer have any possible power over China, Russian and Iran. So who gives a fuck about MMJ if we get crushed by a much worst government.
BarnBuster
Virtually Unknown Member
this from High Times 8/3/2106
Although the U.S. Drug Enforcement Administration (DEA) announced earlier this year that it would reveal its decision on whether to downgrade the Schedule I listing of cannabis within the first half of 2016, it appears that Uncle Sam’s leading dope henchmen are still at the drawing board—reportedly dissecting the plant in an attempt to determine which compounds may be important for medical use and which ones must remain classified as a public menace.
On Tuesday, DEA spokesperson Russ Baer told the Cannabist that while the agency was not yet prepared to make a determination on rescheduling cannabis, it was in the “final stages” of its eight-factor evaluation process, suggesting that a decision, whatever that might be, is well within reach. However, Baer refused to say when the cannabis community could expect the news.
“I can’t give you a time frame as to when we may announce a decision,” he said. “We’re closer than we were a month ago. It’s a very deliberate process.”
What is known is that the DEA has received “scientific and medical evaluations” along with a scheduling recommendation from the Department of Health and Human Services. A letter dated April 4, 2016 indicates that the agency has met with officials with the U.S Food and Drug Administration and the National Institute on Drug Abuse to assist in the rescheduling debate.
Yet, Baer would not give any indication as to whether those recommendations were in favor of a reschedule or if all of the noise we’ve been hearing on this issue is simply the product of a long con.
All of the wild-eyed hope for a marijuana reschedule really heated up this year when the DEA fired off a letter to Senator Elizabeth Warren in April, suggesting that the agency’s plan was to make a rescheduling announcement “in the first half of 2016.” Of course, confusion surrounding the implications of the DEA’s agenda quickly produced a number of ridiculous reports implying that marijuana was soon to be made legal in every state across the nation. This is far from true.
As it stands, marijuana is classified a Schedule I, dangerous drug under the confines of the Controlled Substances Act. In the eyes of the federal government, this means that anything derived from the cannabis plant has no medicinal value and a high potential for abuse. But a schedule downgrade would make some modest changes to Uncle Sam’s hammer-fisted attitude toward the herb—opening up the plant to be considered as having some worth in the scope of modern medicine.
Yet, unfortunately, it does not sound like the DEA—or the rest of the agencies with their hands in the rescheduling decision—are interested in loosening the restrictions for the entire plant.
Last month, Baer told aNewDomain that the DEA and other governmental agencies were struggling with the cannabis debate because they were still trying to “identify the parts of the plant that might have benefit, and separating out (the beneficial) components and distinguishing which “aren’t beneficial or harmful.”
Therefore, it is conceivable that if and when the DEA’s decision is finally made public, it will be somewhat of a disappointment—possibly only coming with a reschedule for non-intoxicating compounds like cannabidiol (CBD), while leaving our good friend tetrahydrocannabinol (THC) in the ranks of killer substances like heroin.
What is important to understand is that even if the DEA unleashes the cannabis plant, in its full form, very little will change for the average stoner or medical marijuana patient. A recent report from the Brookings Institution indicates that a decision to make marijuana a Schedule II drug would not have any impact on the medical marijuana industry, nor would it lead to national drug store chains, like CVS and Walgreens, stocking their shelves with cannabis products.
What’s more, as Paul Armentano, deputy director of NORML pointed out in his latest analysis, rescheduling cannabis will not even make the herb that much more “accessible for clinical study.”
“These goals can only be accomplished by federally descheduling cannabis in a manner similar to alcohol and tobacco, thus providing states the power to establish their own marijuana policies free from federal intrusion,” Armentano wrote. “If the DEA fails to take this opportunity to take such action, then it is incumbent that Congress does so posthaste.”
Although the U.S. Drug Enforcement Administration (DEA) announced earlier this year that it would reveal its decision on whether to downgrade the Schedule I listing of cannabis within the first half of 2016, it appears that Uncle Sam’s leading dope henchmen are still at the drawing board—reportedly dissecting the plant in an attempt to determine which compounds may be important for medical use and which ones must remain classified as a public menace.
On Tuesday, DEA spokesperson Russ Baer told the Cannabist that while the agency was not yet prepared to make a determination on rescheduling cannabis, it was in the “final stages” of its eight-factor evaluation process, suggesting that a decision, whatever that might be, is well within reach. However, Baer refused to say when the cannabis community could expect the news.
“I can’t give you a time frame as to when we may announce a decision,” he said. “We’re closer than we were a month ago. It’s a very deliberate process.”
What is known is that the DEA has received “scientific and medical evaluations” along with a scheduling recommendation from the Department of Health and Human Services. A letter dated April 4, 2016 indicates that the agency has met with officials with the U.S Food and Drug Administration and the National Institute on Drug Abuse to assist in the rescheduling debate.
Yet, Baer would not give any indication as to whether those recommendations were in favor of a reschedule or if all of the noise we’ve been hearing on this issue is simply the product of a long con.
All of the wild-eyed hope for a marijuana reschedule really heated up this year when the DEA fired off a letter to Senator Elizabeth Warren in April, suggesting that the agency’s plan was to make a rescheduling announcement “in the first half of 2016.” Of course, confusion surrounding the implications of the DEA’s agenda quickly produced a number of ridiculous reports implying that marijuana was soon to be made legal in every state across the nation. This is far from true.
As it stands, marijuana is classified a Schedule I, dangerous drug under the confines of the Controlled Substances Act. In the eyes of the federal government, this means that anything derived from the cannabis plant has no medicinal value and a high potential for abuse. But a schedule downgrade would make some modest changes to Uncle Sam’s hammer-fisted attitude toward the herb—opening up the plant to be considered as having some worth in the scope of modern medicine.
Yet, unfortunately, it does not sound like the DEA—or the rest of the agencies with their hands in the rescheduling decision—are interested in loosening the restrictions for the entire plant.
Last month, Baer told aNewDomain that the DEA and other governmental agencies were struggling with the cannabis debate because they were still trying to “identify the parts of the plant that might have benefit, and separating out (the beneficial) components and distinguishing which “aren’t beneficial or harmful.”
Therefore, it is conceivable that if and when the DEA’s decision is finally made public, it will be somewhat of a disappointment—possibly only coming with a reschedule for non-intoxicating compounds like cannabidiol (CBD), while leaving our good friend tetrahydrocannabinol (THC) in the ranks of killer substances like heroin.
What is important to understand is that even if the DEA unleashes the cannabis plant, in its full form, very little will change for the average stoner or medical marijuana patient. A recent report from the Brookings Institution indicates that a decision to make marijuana a Schedule II drug would not have any impact on the medical marijuana industry, nor would it lead to national drug store chains, like CVS and Walgreens, stocking their shelves with cannabis products.
What’s more, as Paul Armentano, deputy director of NORML pointed out in his latest analysis, rescheduling cannabis will not even make the herb that much more “accessible for clinical study.”
“These goals can only be accomplished by federally descheduling cannabis in a manner similar to alcohol and tobacco, thus providing states the power to establish their own marijuana policies free from federal intrusion,” Armentano wrote. “If the DEA fails to take this opportunity to take such action, then it is incumbent that Congress does so posthaste.”
Rrog
Well-Known Member
It's such a tangled web of bullshit.
People say "Oh no, it's very simple... just legalize it." It's much more complex than that, there are trillion-dollar industries involved, an entire justice system whose foundation is weed. Sure this all sucks, but to deny the clear pressure and human power hunger and greed, it's pretty easy to see why this has been such a bitch for us for so long.
More old people need to pass away
People say "Oh no, it's very simple... just legalize it." It's much more complex than that, there are trillion-dollar industries involved, an entire justice system whose foundation is weed. Sure this all sucks, but to deny the clear pressure and human power hunger and greed, it's pretty easy to see why this has been such a bitch for us for so long.
More old people need to pass away
BarnBuster
Virtually Unknown Member
the decision
Similar threads
